Rockwell Medical Inc represents a strong commitment to delivering innovative solutions in the healthcare industry. Their corporate philosophy revolves around patient care, scientific advancements, and improving the quality of life for patients. With a focus on research and development, Rockwell Medical Inc aims to provide effective and cost-efficient treatments for various medical conditions. The company is driven by a dedication to excellence, integrity, and creating value for shareholders. Rockwell Medical Inc prioritizes patient safety, product quality, and regulatory compliance, positioning themselves as a trusted and reliable partner in the healthcare sector.

Rockwell Medical Inc is primarily present in the United States.

Rockwell Medical Inc has achieved significant milestones throughout its history. The company developed and received approval for its iv iron replacement therapy, Triferic, in the United States. Triferic has proven to be a revolutionary treatment for anemia in patients undergoing hemodialysis. Rockwell Medical Inc also expanded its product portfolio with the launch of Dialysate Triferic, an innovative iron delivery product for hemodialysis patients. In addition, the company successfully completed clinical trials and obtained regulatory approvals, solidifying its position in the market. These milestones demonstrate Rockwell Medical Inc's commitment to providing groundbreaking solutions for patients in need of effective and safe therapies for managing iron deficiency anemia.

Rockwell Medical Inc is a pharmaceutical company specializing in the development and commercialization of innovative therapeutic products. Founded in 1995, Rockwell Medical Inc has a rich history of providing solutions for patients with complex medical conditions. The company is dedicated to improving outcomes and quality of life for patients worldwide. With a strong focus on research and development, Rockwell Medical Inc has pioneered cutting-edge treatments in the field of dialysis and iron deficiency anemia. Their commitment to innovation and patient care has solidified their position as a trusted leader in the healthcare industry.

The main competitors of Rockwell Medical Inc in the market are Amgen Inc, Akebia Therapeutics Inc, and FibroGen Inc. These companies compete in the biopharmaceutical sector and offer similar products and services as Rockwell Medical Inc. Their presence and competition in the market drive innovation and encourage continuous improvement within the industry. Maintaining a strong market position and distinguishing unique offerings are crucial for Rockwell Medical Inc to stay ahead of its competitors.

Rockwell Medical Inc is primarily active in the pharmaceutical and healthcare industries.

The business model of Rockwell Medical Inc revolves around the development, manufacture, and commercialization of innovative products and services in the field of hemodialysis. As a biopharmaceutical company, Rockwell Medical Inc focuses on providing integrated solutions to improve patient outcomes and enhance the quality of life for individuals with kidney disease. Their primary product, Triferic, is a unique, iron-replacement therapy that helps manage anemia in hemodialysis patients. With a commitment to scientific excellence and continuous advancements, Rockwell Medical Inc strives to make a significant impact on the healthcare industry while ensuring the highest standards of patient care.

Rockwell Medical hissesinin F/K oranı -10,73.

Rockwell Medical KUV 0,47 dir.

Rockwell Medical için AlleAktien Kalite Skoru 3/10'dur.

beklenen Rockwell Medical cirosu 94,34 Milyon. USD dir.

beklenen Rockwell Medical karı -4,18 Milyon. USD olarak gerçekleşmiştir.

Rockwell Medical is a US-based company headquartered in Michigan that specializes in the development and marketing of products for the treatment of iron deficiency conditions in dialysis patients. The company has been listed on the NASDAQ stock exchange since 1996 and has introduced its products in multiple countries worldwide. The business model of Rockwell Medical is based on the manufacturing and marketing of pharmaceuticals and medical devices in various areas. It provides solutions for the clinical care of dialysis patients affected by chronic kidney failure or other conditions causing iron deficiency. The main areas of focus for Rockwell Medical include dialysis treatment and hematological disorders. In the field of dialysis treatment, the company offers dialyzers as medical devices to kidney patients with chronic iron deficiency, which can be used by dialysis centers to cleanse the patient's blood of waste substances. The company also produces the pharmaceutical product Triferic, which is used as an iron replacement in dialysis treatment. For hematological disorders, Rockwell Medical offers the product Calcitriol, which regulates calcium metabolism and promotes the production of red blood cells. Calcitriol is used for the treatment of renal osteodystrophies caused by disorders in calcium and phosphate metabolism. In addition to these areas, Rockwell Medical also has a technological division that focuses on the discovery of new products and procedures for the treatment of chronic diseases. This division supports the research and development of medications and medical devices for the treatment of kidney, liver, cardiovascular, and other diseases. Overall, Rockwell Medical's business model is aimed at providing holistic treatment for dialysis patients by offering innovative products and solutions for their needs. The company works closely with dialysis centers, medical professionals, and other partners to ensure optimal care for patients. In summary, Rockwell Medical is a leading manufacturer of dialysis products and medications for the treatment of iron deficiency conditions. Its products and solutions aim to improve the quality of life for dialysis patients and make life easier for people with chronic diseases. The company relies on research and innovation to strengthen its position in the industry and expand its product range.

Rockwell Medical, yılda kez dağıtılmak üzere 0 USD tutarında temettü ödemektedir.

Rockwell Medical için şu an için temettü hesaplanamıyor veya şirket temettü dağıtmıyor.

Rockwell Medical şirketinin ISIN kodu US7743741024’dir.

Rockwell Medical 'nin WKN'si 916118 'dir.

Rockwell Medical için Ticker RMTI’dir.

Son 12 ay içerisinde Rockwell Medical, tutarında bir temettü ödedi. Bu, yaklaşık olarak oranında bir temettü verimine denk gelmektedir. Gelecek 12 ay için Rockwell Medical, tahmini olarak 0 USD tutarında bir temettü ödemesi yapacak.

Rockwell Medical şirketinin mevcut temettü verimi .

Rockwell Medical dönemsel olarak temettü ödemesi yapar. Bu ödemeler aylarında gerçekleştirilir.

Rockwell Medical, son 0 yıl içerisinde her yıl temettü ödedi.

Önümüzdeki 12 ay için 0 USD tutarında temettü ödenmesi beklenmektedir. Bu, 0 % oranında bir temettü verimidir.

Rockwell Medical, 'Sağlık' sektörüne atanmıştır.

Son Rockwell Medical tarihinde 0 USD tutarındaki en son temettüyü alabilmek için, hisseyi 22.07.2024 tarihindeki Ex-Tag'den önce portföyünde bulundurman gerekiyordu.

Son ödeme tarihi 22.07.2024 olarak gerçekleşti.

2023 yılında Rockwell Medical tarafından 0 USD olarak temettüler dağıtıldı.

Rockwell Medical hisselerinin temettüleri USD olarak dağıtılır.